0000899243-19-005202.txt : 20190228 0000899243-19-005202.hdr.sgml : 20190228 20190228160938 ACCESSION NUMBER: 0000899243-19-005202 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190226 FILED AS OF DATE: 20190228 DATE AS OF CHANGE: 20190228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARNER CAM L CENTRAL INDEX KEY: 0001024007 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 19643264 MAIL ADDRESS: STREET 1: PO BOX 675866 CITY: RANCHO SANTE FE STATE: CA ZIP: 92067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-26 0 0001375151 ZOGENIX, INC. ZGNX 0001024007 GARNER CAM L C/O ZOGENIX, INC. 5858 HORTON STREET, #455 EMERYVILLE CA 94608 1 0 0 0 Common Stock 2019-02-26 4 M 0 4756 12.00 A 4756 D Common Stock 2019-02-26 4 S 0 4756 50.00 D 0 D Common Stock 2019-02-27 4 M 0 869 12.00 A 869 D Common Stock 2019-02-27 4 S 0 869 50.00 D 0 D Common Stock 40843 I By Garner Investments, LLC Stock Option (Right to Buy) 12.00 2019-02-26 4 M 0 4756 0.00 D 2023-06-18 Common Stock 4756 869 D Stock Option (Right to Buy) 12.00 2019-02-27 4 M 0 869 0.00 D 2023-06-18 Common Stock 869 0 D The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. The Reporting Person is the managing member of Garner Investments, LLC. The Option was granted on June 18, 2013 and vests in a series of twelve (12) successive, equal monthly installments beginning on the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. /s/ Thomas Doyle, Attorney-in-fact for Cam L. Garner 2019-02-28